Vanguard Group’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-994,997
| Closed | -$1.8M | – | 4589 |
|
|
2023
Q2 | $1.8M | Sell |
994,997
-140,552
| -12% | -$254K | ﹤0.01% | 3700 |
|
|
2023
Q1 | $1.5M | Buy |
1,135,549
+5,358
| +0.5% | +$7.07K | ﹤0.01% | 3782 |
|
|
2022
Q4 | $1.91M | Buy |
1,130,191
+6,333
| +0.6% | +$10.7K | ﹤0.01% | 3672 |
|
|
2022
Q3 | $2.08M | Buy |
1,123,858
+21,824
| +2% | +$40.4K | ﹤0.01% | 3726 |
|
|
2022
Q2 | $3.38M | Buy |
1,102,034
+116,060
| +12% | +$356K | ﹤0.01% | 3568 |
|
|
2022
Q1 | $7.12M | Buy |
+985,974
| New | +$7.12M | ﹤0.01% | 3329 |
|